Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
08/09/2012 | WO2012047265A3 Improved adjuvant system for vaccine administration |
08/09/2012 | US20120204281 Drg11-responsive (dragon) gene family |
08/09/2012 | US20120204280 Drg11-responsive (dragon) gene family |
08/09/2012 | US20120204276 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis |
08/09/2012 | US20120202884 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
08/09/2012 | US20120202875 Method Of Treatment |
08/09/2012 | US20120202874 Antisense oligonucleotide modulation of stat3 expression |
08/09/2012 | US20120202865 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
08/09/2012 | US20120202848 Therapy of autoimmune colitis using a tip60 inhibitor |
08/09/2012 | US20120202841 Topical Compositions Comprising Ascomycins |
08/09/2012 | US20120202836 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity |
08/09/2012 | US20120202818 Ureidophenyl substituted triazine derivatives and their therapeutical applications |
08/09/2012 | US20120202812 Heteroaryls and uses thereof |
08/09/2012 | US20120202805 PI3K (delta) SELECTIVE INHIBITORS |
08/09/2012 | US20120202799 Condensed Azepine Derivatives As Bromodomain Inhibitors |
08/09/2012 | US20120202788 Azabenzothiazole compounds, compositions and methods of use |
08/09/2012 | US20120202785 Heterocyclic compounds and methods of use |
08/09/2012 | US20120202782 Compounds and compositions as itpkb inhibitors |
08/09/2012 | US20120202769 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
08/09/2012 | US20120202763 Methods for treating cancer and non-neoplastic conditions |
08/09/2012 | US20120202762 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
08/09/2012 | US20120202758 Core 2glcnac-t inhibitors |
08/09/2012 | US20120202733 Inhibition of trem receptor signaling with peptide variants |
08/09/2012 | US20120201903 Cytoprotective or therapeutic plant composition |
08/09/2012 | US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications |
08/09/2012 | US20120201872 Liposomes comprising a calcium phosphate-containing precipitate |
08/09/2012 | US20120201856 Use of Mycobacterium Bovis BCG killed by Extended Freeze Drying (EFD) For Preventing or Treating Atherosclerosis |
08/09/2012 | US20120201855 Modified flagellin improved toll-like receptor 5 stimulating activity |
08/09/2012 | US20120201854 Modified flagellin improved toll-like receptor 5 stimulating activity |
08/09/2012 | US20120201852 Vaccines Against Japanese Encephalitis Virus and West Nile Virus |
08/09/2012 | US20120201851 Generic assay for detection of influenza viruses |
08/09/2012 | US20120201850 Infectious bovine viral diarrhea virus |
08/09/2012 | US20120201849 Vaccine stabilizer |
08/09/2012 | US20120201848 Isolation of a virus related to canine parvovirus-2 from a raccoon |
08/09/2012 | US20120201847 Vaccine Formulations and Uses Thereof |
08/09/2012 | US20120201846 Polymer particles and uses thereof |
08/09/2012 | US20120201845 Transcutaneous immunization without heterologous adjuvant |
08/09/2012 | US20120201844 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
08/09/2012 | US20120201843 Cyp1b1 nucleic acids and methods of use |
08/09/2012 | US20120201841 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
08/09/2012 | US20120201840 EphA2 T-Cell Epitopes and Uses Therefor |
08/09/2012 | US20120201839 Allergy treatment using acid treated aqueous whey protein extract |
08/09/2012 | US20120201836 Methods and compositions for modulating t cell and/or b cell activation |
08/09/2012 | US20120201831 Human antibodies that bind human il-12 and methods for producing |
08/09/2012 | US20120201827 Anti-cd38 antibodies |
08/09/2012 | US20120201826 Anti-RANTES Antibodies and Methods of Use Thereof |
08/09/2012 | US20120201825 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection |
08/09/2012 | US20120201824 Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity |
08/09/2012 | US20120201823 April antagonists and methods of use |
08/09/2012 | US20120201818 Treatment of multiple sclerosis |
08/09/2012 | US20120201814 Compositions monovalent for cd28 binding and methods of use |
08/09/2012 | US20120201813 Polypeptide variants with altered effector function |
08/09/2012 | US20120201807 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
08/09/2012 | US20120201799 Devices, systems and methods for cell modification |
08/09/2012 | US20120201791 Methods of treating diseases or conditions using mesenchymal stem cells |
08/09/2012 | US20120201779 Antihistamine and antihistamine-like nasal application, products |
08/09/2012 | US20120201756 Plasma kallikrein binding proteins |
08/09/2012 | US20120201749 NP-1 Antagonists and Their Therapeutic Use |
08/09/2012 | CA2826453A1 Use of an anti-cd200 antibody for prolonging the survival of allografts |
08/09/2012 | CA2826420A1 Expandable liquid volume in an led bulb |
08/09/2012 | CA2825786A1 Externally-used drug for treating skin disorder and method for producing same |
08/09/2012 | CA2824089A1 Selection and treatment of subjects |
08/08/2012 | EP2484696A1 Antagonistic human light-specific human monoclonal antibodies |
08/08/2012 | EP2484688A1 Peptide epoxyketones for proteasome inhibition |
08/08/2012 | EP2484664A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
08/08/2012 | EP2484378A1 Hepatitis c virus vaccine composition |
08/08/2012 | EP2484354A1 Antioxidant composition |
08/08/2012 | EP2484353A1 Oral composition for alleviation of ultraviolet radiation-induced damage |
08/08/2012 | EP2483268A1 Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases |
08/08/2012 | EP2482854A2 Agents, uses and methods |
08/08/2012 | EP2482811A2 Method and system for accessing patient data |
08/08/2012 | EP2482810A2 Dosage regimen of an s1p receptor modulator |
08/08/2012 | EP2205253B1 Composition and method inhibiting inflammation |
08/08/2012 | EP2090318B1 Prophylactic tuberculosis vaccine |
08/08/2012 | EP2005171B1 Inflammation-inhibitory serum factors and uses thereof |
08/08/2012 | EP1913954B1 Use of the eda domain of fibronectin |
08/08/2012 | EP1777217B1 Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
08/08/2012 | EP1622646B1 Treatment of lupus targeting the macrophages or the folate receptor |
08/08/2012 | EP1169038B1 Cyclic protein tyrosine kinase inhibitors |
08/08/2012 | EP1054664B1 Method for modulating macrophage activation |
08/08/2012 | EP0951551B2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
08/08/2012 | CN1930288B Cells of which genome is modified |
08/08/2012 | CN1576281B Viral clearance process |
08/08/2012 | CN102630167A Treatment of neurological conditions |
08/08/2012 | CN102627640A Heterobicyclic compounds useful as p38 kinase inhibiting agents |
08/08/2012 | CN102627631A Benzoheterocycle compound and preparation method as well as medical application thereof |
08/08/2012 | CN102627578A Phenyl benzylamine compound and application thereof |
08/08/2012 | CN102626471A Traditional Chinese medicine composition with effects of anti-anaphylaxis, desensitization, repair and regeneration |
08/08/2012 | CN102626459A Method for compound enzyme-hot water extraction of cortex phellodendri alkaloids |
08/08/2012 | CN102626452A Hawthorn, radix puerariae, gingko and balsam pear four-in-one flavone capsule |
08/08/2012 | CN102626439A Chinese medicinal preparation for preventing and treating cold and respiratory disease |
08/08/2012 | CN102626431A Preparation method for instant oviductus ranae particle |
08/08/2012 | CN102626428A Ginkgo leaf extract osmotic pump controlled-release preparation and preparation method thereof |
08/08/2012 | CN102626426A Anti-tumor compound poria cocos preparation and preparation method thereof |
08/08/2012 | CN102626418A Application of pyrola polysaccharide in preparing immunity-enhancing medicaments and health food |
08/08/2012 | CN102626386A Bacilli calmette-gurin polysaccharide nucleic acid inhalation aerosol and preparation method and application thereof |
08/08/2012 | CN102626383A Bilobalide injection and preparation method thereof |
08/08/2012 | CN102145030B Kiwi soft capsule preparation method with functions of regulating immunity and inhibiting tumors |
08/08/2012 | CN102120952B Health wine with functions of nourishing yin and tonifying yang |
08/08/2012 | CN101885784B Method for producing glucomannan by liquid culture of konjac cells |